These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 34126069)

  • 1. Binding of single-mutant epidermal growth factor (EGF) ligands alters the stability of the EGF receptor dimer and promotes growth signaling.
    Pascarelli S; Merzhakupova D; Uechi GI; Laurino P
    J Biol Chem; 2021 Jul; 297(1):100872. PubMed ID: 34126069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular determinants of epidermal growth factor binding: a molecular dynamics study.
    Sanders JM; Wampole ME; Thakur ML; Wickstrom E
    PLoS One; 2013; 8(1):e54136. PubMed ID: 23382875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone-induced phosphorylation of epidermal growth factor (EGF) receptor in 3T3-F442A cells. Modulation of EGF-induced trafficking and signaling.
    Huang Y; Kim SO; Jiang J; Frank SJ
    J Biol Chem; 2003 May; 278(21):18902-13. PubMed ID: 12642595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CR1/CR2 interactions modulate the functions of the cell surface epidermal growth factor receptor.
    Walker F; Orchard SG; Jorissen RN; Hall NE; Zhang HH; Hoyne PA; Adams TE; Johns TG; Ward C; Garrett TP; Zhu HJ; Nerrie M; Scott AM; Nice EC; Burgess AW
    J Biol Chem; 2004 May; 279(21):22387-98. PubMed ID: 15016810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laser capture microdissection and protein microarray analysis of human non-small cell lung cancer: differential epidermal growth factor receptor (EGPR) phosphorylation events associated with mutated EGFR compared with wild type.
    VanMeter AJ; Rodriguez AS; Bowman ED; Jen J; Harris CC; Deng J; Calvert VS; Silvestri A; Fredolini C; Chandhoke V; Petricoin EF; Liotta LA; Espina V
    Mol Cell Proteomics; 2008 Oct; 7(10):1902-24. PubMed ID: 18687633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor receptors containing a single tyrosine in their C-terminal tail bind different effector molecules and are signaling-competent.
    Gill K; Macdonald-Obermann JL; Pike LJ
    J Biol Chem; 2017 Dec; 292(50):20744-20755. PubMed ID: 29074618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand regulates epidermal growth factor receptor kinase specificity: activation increases preference for GAB1 and SHC versus autophosphorylation sites.
    Fan YX; Wong L; Deb TB; Johnson GR
    J Biol Chem; 2004 Sep; 279(37):38143-50. PubMed ID: 15231819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenesis reveals a role for epidermal growth factor receptor extracellular subdomain IV in ligand binding.
    Saxon ML; Lee DC
    J Biol Chem; 1999 Oct; 274(40):28356-62. PubMed ID: 10497195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herstatin, an autoinhibitor of the human epidermal growth factor receptor 2 tyrosine kinase, modulates epidermal growth factor signaling pathways resulting in growth arrest.
    Justman QA; Clinton GM
    J Biol Chem; 2002 Jun; 277(23):20618-24. PubMed ID: 11934884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exogenous ganglioside GD1a enhances epidermal growth factor receptor binding and dimerization.
    Liu Y; Li R; Ladisch S
    J Biol Chem; 2004 Aug; 279(35):36481-9. PubMed ID: 15215248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transmembrane signaling by epidermal growth factor receptors lacking autophosphorylation sites.
    Decker SJ
    J Biol Chem; 1993 May; 268(13):9176-9. PubMed ID: 8387484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A ligand-inducible epidermal growth factor receptor/anaplastic lymphoma kinase chimera promotes mitogenesis and transforming properties in 3T3 cells.
    Piccinini G; Bacchiocchi R; Serresi M; Vivani C; Rossetti S; Gennaretti C; Carbonari D; Fazioli F
    J Biol Chem; 2002 Jun; 277(25):22231-9. PubMed ID: 11919185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization of a receptor reserve for effective amplification of mitogenic signaling by an epidermal growth factor mutant deficient in receptor activation.
    Nandagopal K; Popp DM; Niyogi SK
    J Cell Biochem; 2001 Aug 1-9; 83(2):326-41. PubMed ID: 11573249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative experimental/theoretical studies on the EGFR dimerization under the effect of EGF/EGF analogues binding: Highlighting the importance of EGF/EGFR interactions at site III interface.
    Mehrabi M; Mahdiuni H; Rasouli H; Mansouri K; Shahlaei M; Khodarahmi R
    Int J Biol Macromol; 2018 Aug; 115():401-417. PubMed ID: 29665393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone alters epidermal growth factor receptor binding affinity via activation of extracellular signal-regulated kinases in 3T3-F442A cells.
    Huang Y; Chang Y; Wang X; Jiang J; Frank SJ
    Endocrinology; 2004 Jul; 145(7):3297-306. PubMed ID: 15070853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biased signaling downstream of epidermal growth factor receptor regulates proliferative versus apoptotic response to ligand.
    Ali R; Brown W; Purdy SC; Davisson VJ; Wendt MK
    Cell Death Dis; 2018 Sep; 9(10):976. PubMed ID: 30250119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational stability of the epidermal growth factor (EGF) receptor as influenced by glycosylation, dimerization and EGF hormone binding.
    Taylor ES; Pol-Fachin L; Lins RD; Lower SK
    Proteins; 2017 Apr; 85(4):561-570. PubMed ID: 28019699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitosis-specific negative regulation of epidermal growth factor receptor, triggered by a decrease in ligand binding and dimerization, can be overcome by overexpression of receptor.
    Kiyokawa N; Lee EK; Karunagaran D; Lin SY; Hung MC
    J Biol Chem; 1997 Jul; 272(30):18656-65. PubMed ID: 9228035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different epidermal growth factor (EGF) receptor ligands show distinct kinetics and biased or partial agonism for homodimer and heterodimer formation.
    Macdonald-Obermann JL; Pike LJ
    J Biol Chem; 2014 Sep; 289(38):26178-26188. PubMed ID: 25086039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor.
    Swindle CS; Tran KT; Johnson TD; Banerjee P; Mayes AM; Griffith L; Wells A
    J Cell Biol; 2001 Jul; 154(2):459-68. PubMed ID: 11470832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.